G970R-CFTR Mutation (c.2908G>C) Results Predominantly in a Splicing Defect.
Ontology highlight
ABSTRACT: In previous work, participants with a G970R mutation in cystic fibrosis transmembrane conductance regulator (CFTR) (c.2908G>C) had numerically lower sweat chloride responses during ivacaftor treatment than participants with other CFTR gating mutations. The objective of this substudy was to characterize the molecular defect of the G970R mutation in vitro and assess the benefit of ivacaftor in participants with this mutation. This substudy assessed sweat chloride, spirometry findings, and nasal potential difference on and off ivacaftor treatment in three participants with a G970R/F508del genotype. Intestinal organoids derived from rectal biopsy specimens were used to assess ivacaftor response ex vivo and conduct messenger RNA splice and protein analyses. No consistent or meaningful trends we
SUBMITTER: Fidler MC
PROVIDER: S-EPMC7993255 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA